ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
31 announcements with these filters
Thirumalai Chemicals Limited announced the sale of 14.6 lakh equity shares of Ultramarine & Pigments Limited. This reduces the company's holding from 14.38% to 9.38%.
Thirumalai Chemicals will sell up to 14,60,000 shares (5% stake) in Ultramarine & Pigments Limited. The divestment is expected to be completed within seven working days.
M/s. Walker Chandiok & Co LLP resigned as the statutory auditor of Thirumalai Chemicals Limited's material subsidiary, TCL Intermediates Private Limited, effective August 28, 2026.
Thirumalai Chemicals received a show cause notice under Section 74 of the CGST Act involving a tax demand of ₹0.33 Crore.
Thirumalai Chemicals Limited received a credit rating downgrade from ICRA to [ICRA]BBB (Negative) and [ICRA]A3+ across various long-term and short-term debt instruments.
Thirumalai Chemicals conducted its 53rd Annual General Meeting on August 07, 2026. The company shared the meeting proceedings, e-voting results, and the scrutinizer's report.
TCL reported Q1 FY27 consolidated revenue of INR 550 Cr with a net loss of INR 44 Cr. Focus remains on completing the strategic US project and optimizing domestic operations.
Thirumalai Chemicals Limited board has approved a proposal for fund raising. The specific mode and quantum of the issuance are yet to be determined.
Thirumalai Chemicals filed its quarterly Statement of Deviation under Regulation 32, confirming no deviations in the utilization of funds from its preferential issuance.
Thirumalai Chemicals Ltd reported revenue from operations of ₹546.7 Cr (+21.5% YoY) and a net loss of ₹43.7 Cr for Q1 FY27.
Thirumalai Chemicals received a GST show cause notice for Rs. 22.93 Crore from the Commercial Tax Department, Tamil Nadu. The company intends to challenge the demand.
Thirumalai Chemicals announced a board meeting on August 4, 2026, to approve quarterly financial results and discuss a proposal for fund-raising.
Thirumalai Chemicals Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026, as per regulatory requirements.
Motilal Oswal Mutual Fund (a non-promoter entity) disposed of 1,51,245 shares of Thirumalai Chemicals Ltd through market transactions.
Thirumalai Chemicals Limited has submitted its Business Responsibility & Sustainability Report for FY 2025-26. The report details the company's ESG performance and sustainability initiatives.
Thirumalai Chemicals convened its 53rd AGM for August 7, 2026. Key agenda items include adopting financial statements, appointing statutory auditors, and approving director commissions.
Thirumalai Chemicals released its FY 2025-26 Annual Report and 53rd AGM notice. Key financial highlights include Rs.1,393 Crore total income and Rs.20 Crore EBITDA.
Thirumalai Chemicals shareholders approved a special resolution via postal ballot to allow pledge creation for subsidiary loans. The resolution passed with 99.76% assent.
ICRA reaffirmed Thirumalai Chemicals' long-term rating at [ICRA]BBB+ with a negative outlook. The action reflects periodic monitoring post Q4FY2026 results.
Thirumalai Chemicals Limited approved the appointment of PKF Sridhar & Santhanam, LLP as Statutory Auditors for five years. The firm brings extensive chemical industry audit expertise.
Thirumalai Chemicals Limited submitted its Annual Secretarial Compliance Report for the financial year 2025-26. The auditor confirmed general regulatory compliance with pending appeals on prior committee composition matters.
Thirumalai Chemicals Limited reported zero deviation in the utilization of ₹56.14 Crore raised through a preferential issue. Funds were deployed for capital expenditure and general corporate purposes.
Thirumalai Chemicals Ltd reported revenue from operations of ₹424.2 Cr (-18.9% YoY) and a net loss of ₹28 Cr for Q4 FY26.
Thirumalai Chemicals approved its FY26 audited financial results and scheduled its 53rd AGM for August 07, 2026. The board also appointed M/s. PKF Sridhar & Santhanam as statutory auditors.
Thirumalai Chemicals scheduled a board meeting for May 30, 2026, to audit fiscal 2026 financial results. This advance notice provides transparency on upcoming performance disclosures.
Thirumalai Chemicals seeks shareholder approval via postal ballot for a $140 million loan facility for its US subsidiary. The funds will support greenfield manufacturing expansion.
Thirumalai Chemicals Limited has executed a Rs. 65 Crore Loan Agreement with Ultramarine & Pigments Limited. The loan has a 3-year tenure with 10% annual interest compounded quarterly. As a related party transaction between promoter group members, the agreement was concluded at arm's length.
Thirumalai Chemicals Limited has executed a ₹65 Crore loan agreement with Ultramarine & Pigments Limited. The loan carries a 10% annual interest rate compounded quarterly with a 3-year tenure. The transaction is a related party deal conducted at arm's length for general corporate purposes.
Thirumalai Chemicals Limited has executed a loan agreement to avail an unsecured inter-corporate loan of ₹65 Crore from Ultramarine & Pigments Limited. The loan carries a 10% annual compounding interest rate with a tenure of 3 years.
Thirumalai Chemicals Ltd informed the exchanges that it does not fall under the 'Large Corporate' criteria for FY 2026-27 per SEBI norms. The company reported outstanding borrowings of ₹570.91 Crore as of March 31, with an A- credit rating from ICRA Limited. This routine regulatory disclosure clarifies the company's debt-raising compliance obligations.